feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

49ers beat sloppy Cardinals

trending

Jaguars affect AFC playoff picture

trending

Jared Goff faces Eagles

trending

Lurie met with A.J. Brown

trending

NFL AFC Standings Updated

trending

Morgan Stanley raises Nvidia target

trending

Eagles defense stops Lions offense

trending

Wells Fargo: Nvidia stock target

trending

DeVonta Smith active Week 11

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Deadly Bacteria in Baby Formula Triggers Nationwide Recall

Deadly Bacteria in Baby Formula Triggers Nationwide Recall

11 Nov

•

Summary

  • Bacteria that causes botulism found in ByHeart infant formula
  • 13 infants hospitalized, no deaths reported as of Nov. 10
  • Recall affects less than 1% of U.S. infant formula supply
Deadly Bacteria in Baby Formula Triggers Nationwide Recall

In a concerning development, a nationwide recall has been issued for two lots of ByHeart Whole Nutrition Infant Formula after the bacteria that causes botulism was detected in the product. The recall comes after a spike in infant botulism cases in babies who had consumed the powdered formula.

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) announced the recall on Nov. 8, 2025. The California Department of Public Health had noticed an increase in infant botulism cases linked to the ByHeart formula and alerted the CDC. Preliminary testing of an open can fed to a sick baby also indicated the presence of the bacteria that produces the deadly botulinum toxin.

So far, 13 infants have been hospitalized due to the contaminated formula, though thankfully no deaths have been reported as of Nov. 10, 2025. The recalled lots, manufactured on April 23 and May 6, 2025, were primarily distributed in July and August of that year. ByHeart has agreed to the voluntary recall but denies the validity of the test results.

While the recalled formula makes up less than 1% of the total infant formula sold in the United States, the incident serves as a stark reminder of the importance of food safety. Parents are advised to immediately dispose of any cans from the affected lots and contact ByHeart for a replacement.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The bacteria that produces the deadly botulinum toxin was found in the ByHeart Whole Nutrition Infant Formula.
As of November 10, 2025, 13 infants have been hospitalized after consuming the tainted ByHeart formula.
The contaminated ByHeart formula has led to infant botulism cases in Oregon and nine other states, though the specific states are not named in the article.

Read more news on

Healthside-arrowUnited Statesside-arrow

You may also like

Salmonella Outbreak Triggers Recall of Popular Supplements

1 day ago • 6 reads

article image

Rare H5N5 Bird Flu Infects Washington Resident

15 Nov • 8 reads

article image

FDA Eases Biosimilar Approvals, but Patent Hurdles Remain

14 Nov • 11 reads

article image

FDA Clears BrainsWay's Deep TMS System for Adolescent Depression Treatment

14 Nov • 12 reads

article image

Global TB Cases Reach Record High in 2024

12 Nov • 66 reads

article image